RetractedArticleMedical science monitor : international medical journal of experimental and clinical research2018

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.

Fengli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.